We have located links that may give you full text access.
Treatment of the infected total knee arthroplasty with insertion of another prosthesis. The effect of antibiotic-impregnated bone cement.
Clinical Orthopaedics and related Research 1994 December
Eighty-six patients with 89 infected total knee arthroplasties were treated with insertion of another prosthesis. Treatment was not according to an established protocol for parameters, such as delay between removal of the infected prosthesis and insertion of the new prosthesis, duration of antibiotics, use of antibiotic-impregnated cement spacers or beads, and use of antibiotic-impregnated cement for prosthetic fixation at revision surgery. Final followup averaged 52 months (range, 6-126 months). Complications occurred in 30 (33.7%) knees, with recurrent deep infection developing in 10 (11.24%) knees. Patient age, medical diagnosis, type of microorganism, duration of parenteral antibiotics, delay between the resection and revision surgery, and use of antibiotic-impregnated cement spacers or beads were not correlated with the cure rate of infection. Use of antibiotic-impregnated bone cement for prosthesis fixation at revision surgery was the only variable that correlated with the cure rate of deep infection. Seven (28%) of the 25 knees without antibiotic-impregnated cement for prosthesis fixation developed recurrent infection compared with 3 (4.7%) of 64 knees with antibiotic-impregnated cement for prosthesis fixation. This difference was statistically significant (p = 0.0025, log-rank test).
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app